Kathryn Flynn, PhD

Professor, Medicine (Hematology and Oncology)

Education

MS, Sociology, University of Wisconsin-Madison
PhD, Population Health Sciences, University of Wisconsin-Madison
Postdoctoral Fellowship, Duke Clinical Research Institute, Durham, NC

Biography

Dr. Flynn is a Professor of Medicine at the Medical College of Wisconsin. Dr. Flynn’s research interests include measure development, patient-reported outcomes, and mixed methods approaches to analyzing and improving patient-provider communication and decision making. Dr. Flynn co-led the development of the PROMIS Sexual Function and Satisfaction measure. She is a co-investigator in NIDDK’s Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) where she led the LURN Recall Study to evaluate how well men and women are able to self-report their lower urinary tract symptoms over various time periods, comparing daily reports to 3-, 7-, and 30-day recalled reports.

Leadership Positions

Senior Scientific Director for Patient-Reported Outcomes Center for International Blood and Marrow Transplant Research

Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence.

(Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE.) J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1321-1328.e3 PMID: 35393248 SCOPUS ID: 2-s2.0-85127492109 04/09/2022
Self-Reported Health Outcomes of Children and Youth with 10 Chronic Diseases.

(Forrest CB, Schuchard J, Bruno C, Amaral S, Cox ED, Flynn KE, Hinds PS, Huang IC, Kappelman MD, Krishnan JA, Kumar RB, Lai JS, Paller AS, Phipatanakul W, Schanberg LE, Sumino K, Weitzman ER, Reeve BB.) J Pediatr. 2022 07;246:207-212.e1 PMID: 35247394 PMCID: PMC9232908 SCOPUS ID: 2-s2.0-85127527752 03/06/2022
Impact of Sleep Disturbance, Physical Function, Depression and Anxiety on Male Lower Urinary Tract Symptoms: Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).

(Glaser AP, Mansfield S, Smith AR, Helfand BT, Lai HH, Sarma A, Yang CC, Taddeo M, Clemens JQ, Cameron AP, Flynn KE, Andreev V, Fraser MO, Erickson BA, Kirkali Z, Griffith JW, LURN Study Group.) J Urol. 2022 07;208(1):155-163 PMID: 35212573 PMCID: PMC9336513 SCOPUS ID: 2-s2.0-85131770623 02/26/2022
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study.

(D'Souza A, Myers J, Cusatis R, Dispenzieri A, Finkel M, Panepinto J, Flynn KE.) Qual Life Res. 2022 Apr;31(4):1083-1092 PMID: 34255276 PMCID: PMC8993595 SCOPUS ID: 2-s2.0-85110447746 07/14/2021
Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.

(Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B.) Transplant Cell Ther. 2022 02;28(2):112.e1-112.e9 PMID: 34757219 PMCID: PMC8915447 SCOPUS ID: 2-s2.0-85121127060 11/11/2021
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.

(Schoenbeck KL, Atallah E, Lin L, Weinfurt KP, Cortes J, Deininger MWN, Kota V, Larson RA, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Schiffer CA, Shah NP, Silver RT, Thompson JE, Flynn KE.) J Natl Cancer Inst. 2022 01 11;114(1):160-164 PMID: 34491344 PMCID: PMC8755495 SCOPUS ID: 2-s2.0-85123645552 09/08/2021
Extension and Evaluation of the PROMIS Sexual Function and Satisfaction Measures for Use in Adults Living With Multiple Sclerosis

(Amtmann D, Bamer AM, Salem R, McMullen K, Beier M, Flynn KE, Foley FW, Weinfurt KP, Wilkie D, Alschuler KN.) Journal of Sexual Medicine. May 2022;19(5):719-728 SCOPUS ID: 2-s2.0-85127332062 05/01/2022
Effective questionnaire design: How to use cognitive interviews to refine questionnaire items.

(Balza JS, Cusatis R, McDonnell SM, Basir MA, Flynn KE.) J Neonatal Perinatal Med. 2022;15(2):345-349 PMID: 35034911 SCOPUS ID: 2-s2.0-85128493459 01/18/2022
Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions.

(Schoenbeck KL, Flynn KE.) Curr Hematol Malig Rep. 2021 12;16(6):491-499 PMID: 34648119 SCOPUS ID: 2-s2.0-85117019103 10/15/2021
PROM Proposal: Analyzing Proxy Reports of Patient-Reported Outcome Measures.

(Flynn KE.) Circ Cardiovasc Qual Outcomes. 2021 11;14(11):e008529 PMID: 34726073 SCOPUS ID: 2-s2.0-85121990792 11/03/2021
Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer.

(Flynn KE, Lin L, Carter J, Baser RE, Goldfarb S, Saban S, Weinfurt KP.) J Sex Med. 2021 10;18(10):1768-1774 PMID: 34446376 PMCID: PMC8490328 SCOPUS ID: 2-s2.0-85113411977 08/28/2021
Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions

(Schoenbeck KL, Flynn KE.) Current Hematologic Malignancy Reports. December 2021;16(6):491-499 SCOPUS ID: 2-s2.0-85117019103 12/01/2021

Kathryn Flynn, PhD